arrow
A

Abdulrazaq G. Habib

Bayero University
H指数:40
被引数:5,783

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Concerns Regarding the Article “Comparative clinical observations following introduction of a new polyvalent antivenom for snakebite envenoming in northern Nigeria” by Hamman et al. Toxicon 266 (2025) 108510

关于Hamman等人发表在《Toxicon》杂志第266卷(2025年)第108510页的论文“Comparative clinical observations following introduction of a new polyvalent antivenom for snakebite envenoming in northern Nigeria”的几点疑虑。

Toxicon
IF2.4
2025-12-150
PRE
Modeling Neisseria meningitidis transmission dynamics and the impact of pentavalent vaccination targeting serogroups A, C, W-135, Y, and X in the African meningitis belt

建立脑膜炎奈瑟菌(Neisseria meningitidis)传播动力学模型,并评估针对A、C、W-135、Y和X血清群进行五价疫苗接种的影响(在非洲脑膜炎带地区)。

2025-12-010
OAAI
Subject: Concerns regarding the article “comparative clinical observations following introduction of a new polyvalent antivenom for snakebite envenoming in northern Nigeria” by Hamman et al. Toxicon 266 (2025) 108510

主题:关于Hamman等人发表在《Toxicon》266卷(2025年)第108510页的论文“在尼日利亚北部引入一种新型多价抗蛇毒血清用于蛇咬中毒后的比较临床观察”的关切。

Toxicon
IF2.4
2025-09-240
PRE
Subject: Concerns regarding the article “comparative clinical observations following introduction of a new polyvalent antivenom for snakebite envenoming in northern Nigeria” by Hamman et al. Toxicon 266 (2025) 108510

主题:关于Hamman等人发表在《Toxicon》266卷(2025年)第108510页的论文“在尼日利亚北部引入一种新型多价抗蛇毒血清治疗蛇咬中毒后的比较临床观察”的关切。

Toxicon
IF2.4
2025-09-240
PRE
A global core outcome measurement set for snakebite clinical trials
2023-02-0114
OAAI